Literature DB >> 21342231

Allergic contact dermatitis due to diclofenac sodium in eye drops.

Hitona Miyazato1, Sayaka Yamaguchi, Kiyohito Taira, Yutaka Asato, Yu-Ichi Yamamoto, Keisuke Hagiwara, Hiroshi Uezato.   

Abstract

Eyelid dermatitis and/or periocular dermatitis (ED/PD) is commonly seen in a variety of skin diseases such as seborrheic dermatitis, atopic dermatitis and psoriasis, but is most often associated with allergic contact dermatitis (ACD). Here, a case of ACD in an 82-year-old man is described; he used 0.1% diclofenac sodium eye drops and exhibited pruritic erythema on the eyelids. Patch test for diclofenac sodium eye drops was positive. Further patch tests revealed a positive reaction to diclofenac sodium (monosodium 2-[2, 6-dichlorophenylamino] phenylacetate), which was the main component in the eye drop medicine. Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID), and is frequently used in everyday oral medications, topical ointments, gel agents and eye drops. Case reports on ACD caused by diclofenac sodium eye drops are extremely rare. Nevertheless, it is necessary to consider ACD due to diclofenac sodium when a patient with ED/PD has a history of use of diclofenac sodium eye drops.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21342231     DOI: 10.1111/j.1346-8138.2010.00934.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

1.  Severe photosensitivity reaction induced by topical diclofenac.

Authors:  Pramod B Akat
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

2.  Eyelid excoriation and erythema with nepafenac eye drop.

Authors:  Kumar Saurabh; Rupak Roy; Debmalya Das; Aneesha Lobo
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

Review 3.  Systemic side effects of eye drops: a pharmacokinetic perspective.

Authors:  Andre Farkouh; Peter Frigo; Martin Czejka
Journal:  Clin Ophthalmol       Date:  2016-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.